Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: A preliminary investigation of circulating extracellular vesicles and biomarker discovery associated with treatment response in head and neck squamous cell carcinoma

Fig. 1

Distribution of specific proteins in the CTB-EVs, AV-EVs and crude plasma detected through Antibody Array assays. The comparison of the protein content in CTB-EVs, AV-EVs and crude plasma from pooled 6 complete responder (CR) patients and 6 non-responder (NR) patients revealed 119 proteins specific to the NR patients, while 38 proteins were specific to the CR patients. The level of protein detected was normalized by the mean of positive controls present in the antibody array assay (Full Moon Biosystems)

Back to article page